Friday, January 29, 2010
Friday, January 22, 2010
Venture Funding Moves from Clean Energy to Efficient Lighting and Energy-Management Software : Biotech Leads the Pack
Venture Funding Stabilizes, Shifts to Biotech, Shuns Energy - BusinessWeek
Biotech is on the rise as drug companies seek to offset expiring patents and as investments are being made in new technologies such as genome and cancer research. Less money is going into clean energy and more into projects for efficient lighting and energy-management software.
Tim Mullaney, January 22, 2010 (Bloomberg) , writes:
Biotech is on the rise as drug companies seek to offset expiring patents and as investments are being made in new technologies such as genome and cancer research. Less money is going into clean energy and more into projects for efficient lighting and energy-management software.
Tim Mullaney, January 22, 2010 (Bloomberg) , writes:
"Venture-capital funding for startup companies stabilized in the fourth quarter, with investor interest shifting toward drug development and away from clean energy....
Biotech was the largest industry for the quarter."
Subscribe to:
Posts (Atom)
Most Popular Posts
-
We posted previously, extensively and definitey about the need to limit biotechnology patents at In re Kubin : Hitting the NAIL on the Head ...
-
The Spread of Superbugs by Nicholas D. Kristof, March 7, 2010, at the New York Times Mobile "A study by the Union of Concerned Scientis...
-
It is often claimed that the liberal granting of patents is essential for the development of the pharmaceutical industry, especially modern ...
-
Text below crossposted from LawPundit . BRAVO to the United States Supreme Court! The unanimous (who would have believed that!) U.S. Supr...
-
Stephen Albainy-Jenei at the blog Patent Baristas has an extensive posting on In re Kubin at Court: It’s Not An Invention If You Use Conven...
